MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Treatments

Home
Treatments
Ocrevus

Ocrevus and PPMS: Where to from here?

MStranslate
September 10, 2018
Ocrelizumab, Opinion, Treatments
The following is an opinion piece written by MStranslate co-founder, Brett Drummond. Let’s rewind to last March last year…there is worldwide excitement as ocrelizumab (Ocrevus) becomes the first treatment...
ibudilast

Ibudilast Phase 2 Trial Results for Progressive MS

MStranslate
August 30, 2018
Progressive MS, Research, Treatments
Research Summary: Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis What is it? Ibudilast is an anti-inflammatory treatment, which also has effects that protect nerves.  It is thought to offer...
primary progressive MS research

Primary Progressive MS Research: Treatment Outcomes

MStranslate
August 9, 2018
Progressive MS, Research, Treatments
PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS Primary progressive multiple sclerosis (PPMS) is characterised by a steady worsening of disease or accumulation of disability from onset without any lengthy periods of...
cannabis for chronic pain

Cannabis and Chronic Pain: Research Summary

MStranslate
July 19, 2018
Medicinal Cannabis, Research, Treatments
Research Summary: Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study WHO? Research was primarily done by a team at the National...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 5

MStranslate
April 26, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
5 Comments
The following is part of a MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies and drugs for human disease. Dr. Travis Stiles is a...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 4

MStranslate
April 10, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
The following is part of a MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies and drugs for human disease. Dr. Travis Stiles is a...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 3

MStranslate
March 27, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
1 Comment
The following is part of a MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies and drugs for human disease. Dr. Travis Stiles is a...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 2

MStranslate
March 20, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
The following is part two of an MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies and drugs for human disease. It is written by Dr. Travis...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 1

MStranslate
March 13, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
1 Comment
The following is part of an MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies and drugs for human disease. Dr. Travis Stiles is a...
multiple sclerosis

Support the Future of Multiple Sclerosis Research

MStranslate
February 28, 2018
Community, Research, Treatments
...
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.